Monitor for the filing of the resale registration statement and any subsequent advance notices. The large gap between the $40M facility and the company's tiny market cap suggests heavy dilution is likely if the company draws on the line. Watch for any pipeline catalysts that could reduce the need to tap the facility.
Price Chart
Executive Summary
BioAtla entered into a new Standby Equity Purchase Agreement (SEPA) with Yorkville for up to $40M in common stock, replacing a prior $15M SEPA under which only $0.4M was drawn. The company issued 182,110 commitment fee warrants to Yorkville as partial consideration. The new facility provides a larger potential equity line but signals ongoing cash needs and potential future dilution.
Key Financial Metrics
Key Facts
- BioAtla entered into a SEPA with YA II PN, Ltd. (Yorkville) for up to $40M of common stock, replacing a prior $15M SEPA.
- Under the prior SEPA, only 48,092 shares were sold for aggregate gross proceeds of approximately $0.4M before termination.
- The company issued Commitment Fee Warrants exercisable for 182,110 shares as payment for the first half of a $500,000 commitment fee.
- Yorkville will purchase shares at 97% of the lowest daily VWAP during a 3-day pricing period, subject to a minimum acceptable price set by BioAtla.
- The SEPA has a 36-month term and is at BioAtla's discretion to draw upon, but the company must first file an effective registration statement.
- As of the filing date, BioAtla had only 1,668,261 common shares outstanding, making the potential dilution from the full $40M facility very significant.
Financial Impact
Up to $40M in potential equity issuance; $500K commitment fee; 182,110 warrants already issued
Risk Factors
- Massive potential dilution: the $40M facility is many times the current market cap of a company with only 1.67M shares outstanding.
- Yorkville's 97%-of-VWAP pricing mechanism creates a built-in discount that could pressure the stock price on any draw.
- The prior SEPA was barely utilized ($0.4M of $15M), suggesting the company may have struggled to draw under the old terms or market conditions were unfavorable.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-425553 |
| Document: bcab-ex4_1.htm | 0001193125-26-425553 |
| Document: bcab-20261015.htm | 0001193125-26-425553 |
| Document: 0001193125-26-425553-index-headers.html | 0001193125-26-425553 |
| Document: 0001193125-26-425553-index.html | 0001193125-26-425553 |
| Document: 0001193125-26-425553.txt | 0001193125-26-425553 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | S-1 | $1.74 | awaiting T+20 | — | $1.71 (+1.44%) |
Oct 19, 2026 6d ago | 8-K | $1.74 | awaiting T+20 | — | $1.71 (+1.44%) |
Aug 28, 2026 8w ago | 8-K | $1.74 $1.74 | · 0.00% | ▲ +0.26% | $1.71 (+1.44%) |
Mar 31, 2026 29w ago | 8-K | $6.75 $4.04 | ▲ +40.15% | ▲ +49.87% | $1.71 (+74.67%) |
Mar 2, 2026 33w ago | DEFA14A | $10.20 $7.70 | ▼ −24.51% | ▼ −16.57% | $1.71 (−83.24%) |
Mar 2, 2026 33w ago | Press Release | $10.20 $7.70 | ▲ +24.51% | ▲ +16.57% | $1.71 (+83.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers